|+ + +
Successfully treating parkinsons disease 1 with NADH - Life's Energy
|NADH: Parkinson's disease (section 1
. . . to previous page, the medical library
Since the mid-eighties, NADH has been successfully used in Europe to treat more than 3,000 Parkinsonian patients. An overwhelming majority (about 80%) of the Parkinsonian patients experienced remarkable improvements. In the other 21.6% of the Parkinsonian patients, the disease had progressed too far. Their disability prior to treatment was too advanced. Too many brain cells had died before the NADH treatment had begun.
Ask your doctor:
All the NADH / Parkinson's disease information we have is included here in this web site. As new relevant information becomes available, we will update these web pages. So don't forget to bookmark this site.
NADH is non-toxic. It can be taken with other medications without any adverse drug interactions. If someone you know needs to take other medications, they can safely take NADH To be certain, you should always check with your doctor or healthcare professional before taking any nutritional supplement.
Definition of Parkinsons
Parkinson's disease usually refers to similar symptoms resulting from certain anti-psychotic drugs (taken by the mentally ill), reserpine (a blood pressure drug), carbon monoxide poisoning, or MPTP (a heroin byproduct).
Parkinsons disease is treated with these common drugs: sinemet, deprenyl (selegiline), L-DOPA (given with carbidopa to reduce side effects) and amantadine. Parkinsons sufferers can take tacrine and Co-E1® / NADH. Testing shows no negative interactions. Parkinsons disease is named for the English surgeon James Parkinson, who first described it in 1817.
Definition of the neurotransmitter: dopamine
The findings in clinical
In a recent, open label trial of 885 patients, NADH was used as the medication in the treatment of Parkinson's disease. About half of the patients received NADH by intravenous infusion, the other half by oral tablets. Patients that received NADH oral tablets experienced better results. You can get the same NADH oral tablet here at this web site. The NADH oral tablet is called Co-E1®.
We have included the Parkinson's disease clinical trial results in this web site. It is very difficult to read, because of the technical nature of the document. The clinical trial study results are usually read by medical professionals. It can be used for people who want to bring the actual clinical research study to their doctor or health care professional.
. . . Parkinson disease 2, continued on the next page
Last modified: May 2nd 2013